Article 1,2,4-Triazole 2 [(5 {1 [(4 methoxyphenyl)sulfonyl] 4 piperidinyl} 4 phenyl 4h 1,2,4 triazol 3 yl)sulfanyl] n (2 methylphenyl)acetamide 2 [(5 {1 [(4 methoxyphenyl)sulfonyl] 4 piperidinyl} 4 phenyl 4h 1,2,4 triazol 3 yl)sulfanyl] n (3 methylphenyl)acetamide 2 [(5 {1 [(4 methoxyphenyl)sulfonyl] 4 piperidinyl} 4 phenyl 4h 1,2,4 triazol 3 yl)sulfanyl] n (4 methylphenyl)acetamide Antiretroviral therapy Broadly Neutralizing Antibodies Broadly neutralising antibodies Butyrylcholinesterase inhibition CD4 antigen COVID-19 Clinical Trials, Phase II as Topic Community Participation Convolutional neural networks DPPH radical scavenging assay Data acquisition Depression database Depression prediction Machine learning Deep learning Emotion recognition Ethyl isonipecotate Google colab HIV HIV Antibodies HIV Infections HIV-1 Human immunodeficiency virus Human immunodeficiency virus 1 Human immunodeficiency virus antibody Human immunodeficiency virus infected patient Human immunodeficiency virus infection Humans